NeuBase Therapeutics (NBSE)
(Delayed Data from NSDQ)
$0.44 USD
0.00 (-0.54%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $0.44 0.00 (0.09%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/13/2024
Time: -- |
12/2023 | $-0.97 | 0.00% |
Earnings Summary
For their last quarter, NeuBase Therapeutics (NBSE) reported earnings of -$0.95 per share, beating the Zacks Consensus Estimate of $-1.82 per share. This reflects a positive earnings surprise of 47.80%. Look out for NBSE's next earnings release expected on February 13, 2024. For the next earning release, we expect the company to report earnings of -$0.97 per share, reflecting a year-over-year increase of 62.69%.
Earnings History
Price & Consensus
Zacks News for NBSE
What Makes NeuBase (NBSE) a New Strong Buy Stock
NBSE: What are Zacks experts saying now?
Zacks Private Portfolio Services